Hepatocellular carcinoma (HCC) is one of the most common and aggressive human malignancies worldwide and also the second most common cause of cancer-related death, in China. It has an extremely poor prognosis, mainly attributed to the high frequency of intrahepatic metastasis, the recurrence rate still is up to60-70%in5years.
It is a challenge to identify patients who are at a greater risk for tumor recurrence after curative treatment for HCC. Base on traditional clinical characteristic and staging syste...